$60.2 M

CRMD Mkt cap, 20-Sep-2018

$30.8 K

CorMedix Revenue Q2, 2018
CorMedix Gross profit (Q2, 2018)-31.5 K
CorMedix Gross profit margin (Q2, 2018), %(102.3%)
CorMedix Net income (Q2, 2018)-18.7 M
CorMedix EBIT (Q2, 2018)-18.8 M
CorMedix Cash, 30-Jun-20184.7 M

CorMedix Revenue

CorMedix revenue was $329.33 k in FY, 2017

Embed Graph

CorMedix Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

2 k189.3 k210.1 k224.1 k329.3 k

Revenue growth, %

9359%11%7%

Cost of goods sold

201.6 k445.8 k318.7 k366.7 k115 k

Gross profit

(199.6 k)(256.5 k)(108.6 k)(142.6 k)214.4 k

Gross profit Margin, %

(9975%)(136%)(52%)(64%)65%

R&D expense

24.5 m

General and administrative expense

8.7 m

Operating expense total

(33.1 m)

EBIT

(4.9 m)(8.9 m)(16.7 m)(24.8 m)(32.9 m)

EBIT margin, %

(245647%)(4703%)(7926%)(11049%)(9997%)

Interest expense

1.3 k5.6 k

Interest income

668 2.7 k60.4 k126.8 k110.7 k

Pre tax profit

(9.1 m)

Net Income

(55.4 m)(20.5 m)(18.2 m)(24.6 m)(33 m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Revenue

12.2 k39.7 k52.4 k31.3 k120 k35.9 k41.4 k16.5 k44.5 k39.6 k136.2 k23.2 k30.8 k

Cost of goods sold

81 k54.5 k36.7 k17.3 k101.8 k35.4 k50.2 k187.2 k43.9 k93.6 k18.1 k28.6 k62.2 k

Gross profit

(68.8 k)(14.8 k)15.8 k13.9 k18.2 k551 (8.8 k)(170.7 k)529 (54 k)118.1 k(5.4 k)(31.5 k)

Gross profit Margin, %

(564%)(37%)30%45%15%2%(21%)(1034%)1%(137%)87%(23%)(102%)

R&D expense

760.8 k353 k171.9 k292.7 k1.2 m1.8 m1.8 m2.1 m2.8 m6.8 m4.9 m5.1 m8.3 m14.9 m

General and administrative expense

504.5 k2.5 m1.7 m1.6 m4.3 m2.4 m2.9 m2.2 m2 m2.3 m2.6 m2.1 m1.9 m3.8 m

Operating expense total

1.3 m(2.9 m)(1.9 m)(1.9 m)(5.5 m)(4.2 m)(4.7 m)(4.3 m)(4.7 m)(9.2 m)(7.6 m)(7.1 m)(10.2 m)(18.7 m)

EBIT

(1.3 m)(2.9 m)(1.9 m)(1.9 m)(5.5 m)(4.1 m)(4.7 m)(4.3 m)(4.9 m)(9.2 m)(7.6 m)(7 m)(10.2 m)(18.8 m)

EBIT margin, %

(24048%)(4757%)(3554%)(17582%)(3446%)(13110%)(10286%)(29751%)(20602%)(19260%)(5157%)(43898%)(60991%)

Interest expense

859 3.7 k1.6 k992 41 1.9 k1.9 k

Interest income

61 521 987 645 543 8.8 k25 k31.6 k29.4 k32.9 k23.4 k28.6 k14.8 k25 k

Pre tax profit

(2.5 m)(16.7 m)

Net Income

(2.5 m)(16.7 m)3.5 m(5 m)(5.5 m)(4.1 m)(4.7 m)(4.2 m)(4.9 m)(9.1 m)(7.6 m)(5.1 m)(10.2 m)(18.7 m)

CorMedix Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

2.4 m4.3 m11.8 m8.1 m10.4 m

Accounts Receivable

Inventories

80 k166.7 k594.2 k

Current Assets

2.9 m5 m37.1 m21.8 m13.3 m

PP&E

36.1 k41.5 k37.9 k69.7 k186.3 k

Total Assets

3 m5.1 m37.1 m21.9 m13.5 m

Accounts Payable

939.8 k893.4 k1.7 m1.6 m1.8 m

Short-term debt

Current Liabilities

1.7 m1.4 m3.1 m4.1 m6.3 m

Long-term debt

Total Liabilities

4.1 m6.3 m

Additional Paid-in Capital

51.7 m79.7 m128.3 m136.9 m159.2 m

Retained Earnings

(76.2 m)(94.4 m)(119.2 m)(152.2 m)

Total Equity

(4 m)3.6 m34 m17.8 m7.2 m

Financial Leverage

-0.7 x1.4 x1.1 x1.2 x1.9 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Cash

483.1 k9.2 m7.7 m5.9 m8.8 m24.1 m14.2 m13.2 m12 m9.8 m6.8 m7.9 m8.2 m4.7 m

Inventories

270.5 k63.7 k278 k677.4 k461.4 k715 k699.1 k333.9 k157.5 k118.2 k94.9 k313.1 k578.9 k672.9 k

Current Assets

1 m9.7 m8.2 m6.8 m9.7 m38.7 m39.3 m33.6 m31.2 m28.8 m14.9 m21.1 m9.4 m5.7 m

PP&E

3 k33.6 k54.2 k46.9 k47 k44.7 k41.1 k34.8 k31.9 k75.8 k63.2 k57 k205.3 k185.8 k

Total Assets

1 m9.8 m8.3 m6.8 m9.8 m38.8 m39.3 m33.6 m31.2 m28.8 m14.9 m21.2 m9.6 m5.9 m

Accounts Payable

969.8 k1 m848.6 k740.3 k1.4 m1.1 m1.4 m1.6 m1.1 m1.8 m1.7 m1.8 m3.7 m7.3 m

Current Liabilities

3.9 m1.1 m1.2 m1.2 m2.1 m1.9 m2.9 m3.1 m3.1 m5 m3.9 m5.8 m8.8 m12.4 m

Total Liabilities

3.9 m13.5 m9.9 m1.3 m2.2 m1.9 m2.9 m3.1 m3.1 m5.1 m3.9 m5.8 m8.8 m12.4 m

Additional Paid-in Capital

49.5 m68.7 m67.3 m79.4 m89.2 m122.6 m126.8 m129 m131.5 m136.3 m137.7 m147.1 m163 m164.2 m

Retained Earnings

(74 m)(81.7 m)(85.8 m)(90.5 m)(98.6 m)(103.5 m)(112.6 m)(126.8 m)(131.9 m)(162.3 m)(170.9 m)

Total Equity

(2.9 m)(3.7 m)(1.6 m)5.6 m7.6 m36.9 m36.4 m30.5 m28.1 m23.8 m11 m15.4 m840.7 k(6.5 m)

Financial Leverage

-0.4 x-2.6 x-5.2 x1.2 x1.3 x1.1 x1.1 x1.1 x1.1 x1.2 x1.4 x1.4 x11.4 x-0.9 x

CorMedix Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(9.1 m)(20.5 m)(18.2 m)(24.6 m)(33 m)

Depreciation and Amortization

36.9 k

Accounts Receivable

Inventories

80 k(100.5 k)

Accounts Payable

939.8 k893.4 k1.7 m1.6 m157.5 k

Cash From Operating Activities

(28.6 m)

Purchases of PP&E

(152 k)

Cash From Investing Activities

10.4 m

Cash From Financing Activities

20.5 m

Interest Paid

5.6 k

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

(2.5 m)(16.7 m)3.5 m(5 m)(5.5 m)(4.1 m)(4.7 m)(4.2 m)(4.9 m)(9.1 m)(7.6 m)(10.2 m)(18.7 m)

Depreciation and Amortization

19.4 k38.7 k

Inventories

278 k677.4 k15.3 k(78.7 k)

Accounts Payable

848.6 k740.3 k1.4 m1.1 m1.4 m1.6 m1.1 m1.8 m1.7 m1.8 m5.5 m

Cash From Operating Activities

(7.1 m)(11.4 m)

Purchases of PP&E

(38.2 k)(38.2 k)

Cash From Investing Activities

1.6 m1.6 m

Cash From Financing Activities

3.3 m4.1 m

Interest Paid

1.9 k1.9 k

CorMedix Ratios

USDY, 2018

Financial Leverage

-0.9 x
Report incorrect company information